#clinical trial — Thursday, April 16, 2026 (2 items)
| 0 | ℹ |
Ianalumab plus Eltrombopag in Immune Thrombocytopenia.
(nejm.org)
|
New England Journal of Medicine 2026-04-16 | #antibody #clinical trial #immunotherapy #thrombocytopenia | |
| 0 | ℹ |
Asundexian for Secondary Stroke Prevention.
(nejm.org)
|
New England Journal of Medicine 2026-04-16 | #clinical trial #prevention #stroke #thrombosis #anticoagulation |